Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Edge Therapeutics, Inc.

Oklahoma City, Oklahoma, UNITED STATES

OKLAHOMA CITY, June 08, 2018 (GLOBE NEWSWIRE) -- On April 23, 2018, a class action lawsuit was filed in the United States District Court for the District of New Jersey against Edge Therapeutics, Inc. (NASDAQ:EDGE).  Federman & Sherwood reminds current and former shareholders of Edge Therapeutics, Inc. that they only have until Friday, June 22, 2018 to move the court for appointment as a lead plaintiff in this case.  The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you purchased Edge Therapeutics, Inc. shares between December 29, 2017 and March 27, 2018, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible.  Our firm seeks to recover damages on behalf of the Class.  Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud.  We represent investors throughout the country in shareholder litigation.

William B. Federman
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
(405) 235-1560/Fax: (405) 239-2112
Email to: wbf@federmanlaw.com - www.federmanlaw.com